Biogen Idec, Inc.

Biogen Idec, Inc. - 14 Cambridge Center, Cambridge, MA 02142; also facilities in Bedford, OH; Idron, France; Research Triangle Park, NC; and former IDEC facilities in San Diego, CA; Bloomington, IN; Greenville, NC; and Ottawa, Canada; Formed in Nov. 2003 from the merger of Biogen Corp. and IDEC Pharmaceuticals

Related product monographs:

1. B-cell-activating factor Mab, rDNA -- Tech.
2. CD20 Mab, rDNA -- R&D ; Tech.
3. CD20 Mab, humanized, rDNA -- R&D ; Tech. ; USA mark.
4. CD20 Mab, rDNA conc. -- Manuf.
5. CD20 Mab, rDNA/Y-90 & In-111 radioconj, rDNA -- Manuf. ; R&D ; Tech.
6. CTLA4-Ig, rDNA/belatacept -- Patent dispute
7. Hepatitis B Vaccine, rDNA/Merck -- Tech.
8. Hepatitis B Vaccine, rDNA/GSK -- Tech.
9. Hepatitis B vaccine, rDNA/HBVAXPRO -- Tech.
10. Integrin Mab, rDNA -- Manuf. ; R&D ; Tech. ; World mark. ; Former inv.
11. Interferon alfa-2a, rDNA -- Tech.
12. Interferon alfa-2b, rDNA -- Tech.
13. Interferon alfacon-1, rDNA -- Parent
14. Interferon beta-1a, rDNA/Biogen Idec -- Manuf. ; R&D ; Tech. ; USA mark.
15. Interferon beta-1a, rDNA/Merck Serono -- Patent dispute
16. Interferon betaser, rDNA/Bayer -- Patent dispute
17. Interferon betaser, rDNA/Novartis -- Patent dispute
18. Interferon gamma, rDNA -- Tech.
19. Interleukin-2 receptor Mab, rDNA/Roche -- R&D ; World mark.
20. LFA-3/IgG1, rDNA -- Manuf. ; R&D ; Tech.
21. CD20 Mab–I 131 radioconj. -- Tech. ; Patent dispute

Location - Cambridge MA 02142 USA

Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database

Copyright ©2020. Biotechnology Information Institute